Novartis Ag (NVS) Net Shares Issued and Repurchased (2009 - 2025)

Novartis Ag has reported Net Shares Issued and Repurchased for 6 years, with the latest figure at -$2.7 billion in Q2 2025.

• Quarterly Net Shares Issued and Repurchased fell 67.95% year-over-year to -$2.7 billion in Q2 2025, while the trailing twelve-month figure through Jun 2025 was -$10.0 billion (down 37.26% YoY) and the FY2012 annual result came in at $414.0 million, up 160.38% from the prior year.
• Net Shares Issued and Repurchased was little changed at -$2.7 billion in Q2 2025 per NVS's latest filing, from -$2.7 billion in the prior quarter.
• Over five years, Net Shares Issued and Repurchased peaked at -$1.6 billion in Q2 2024 and troughed at -$3.0 billion in Q2 2023.
• A 4-year average of -$2.5 billion and a median of -$2.7 billion in 2022 frame the typical range for Net Shares Issued and Repurchased.
• The sharpest annual moves came in 2024 and 2025: Net Shares Issued and Repurchased soared 45.35% in 2024, then slumped 67.95% in 2025.
• Over 4 years, Net Shares Issued and Repurchased stood at -$2.7 billion in 2022, then retreated by 8.95% to -$3.0 billion in 2023, then rose by 8.18% to -$2.7 billion in 2024, then rose by 0.04% to -$2.7 billion in 2025.
• According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered -$2.7 billion, -$2.7 billion, and -$1.6 billion for Q2 2025, Q4 2024, and Q2 2024 respectively.